vs
ACADIA PHARMACEUTICALS INC（ACAD）与BOSTON BEER CO INC（SAM）财务数据对比。点击上方公司名可切换其他公司
BOSTON BEER CO INC的季度营收约是ACADIA PHARMACEUTICALS INC的1.7倍（$461.6M vs $268.1M），ACADIA PHARMACEUTICALS INC同比增速更快（9.7% vs -4.1%），过去两年ACADIA PHARMACEUTICALS INC的营收复合增速更高（5.3% vs -10.7%）
阿卡迪亚制药是一家总部位于美国加利福尼亚州圣地亚哥德尔马地区的生物制药企业，专注于中枢神经系统相关疾病治疗药物的研发、生产与商业化，致力于为全球患者提供创新的临床治疗方案。
波士顿啤酒公司是美国知名酿酒企业，1984年由吉姆·科赫与朗达·卡尔曼联合创立。旗下首款产品以美国开国元勋、独立运动先驱塞缪尔·亚当斯命名，后续陆续推出多个自有品牌，2019年正式完成与角鲨头酿酒厂的合并，是北美精酿啤酒行业的核心参与者之一。
ACAD vs SAM — 直观对比
营收规模更大
SAM
是对方的1.7倍
$268.1M
营收增速更快
ACAD
高出13.8%
-4.1%
两年增速更快
ACAD
近两年复合增速
-10.7%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $268.1M | $461.6M |
| 净利润 | $3.6M | — |
| 毛利率 | — | 46.4% |
| 营业利润率 | -1.7% | 12.4% |
| 净利率 | 1.4% | — |
| 营收同比 | 9.7% | -4.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.02 | $2.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACADSAM
| Q1 26 | $268.1M | $461.6M | ||
| Q4 25 | $284.0M | $385.7M | ||
| Q3 25 | $278.6M | $537.5M | ||
| Q2 25 | $264.6M | $587.9M | ||
| Q1 25 | $244.3M | $453.9M | ||
| Q4 24 | $259.6M | $402.3M | ||
| Q3 24 | $250.4M | $605.5M | ||
| Q2 24 | $242.0M | $579.1M |
净利润ACADSAM
| Q1 26 | $3.6M | — | ||
| Q4 25 | $273.6M | $-22.5M | ||
| Q3 25 | $71.8M | $46.2M | ||
| Q2 25 | $26.7M | $60.4M | ||
| Q1 25 | $19.0M | $24.4M | ||
| Q4 24 | $143.7M | $-38.8M | ||
| Q3 24 | $32.8M | $33.5M | ||
| Q2 24 | $33.4M | $52.3M |
毛利率ACADSAM
| Q1 26 | — | 46.4% | ||
| Q4 25 | 90.8% | 43.5% | ||
| Q3 25 | 92.2% | 50.8% | ||
| Q2 25 | 92.2% | 49.8% | ||
| Q1 25 | 91.7% | 48.3% | ||
| Q4 24 | 91.6% | 39.9% | ||
| Q3 24 | 92.5% | 46.3% | ||
| Q2 24 | 92.5% | 46.0% |
营业利润率ACADSAM
| Q1 26 | -1.7% | 12.4% | ||
| Q4 25 | 6.1% | -8.6% | ||
| Q3 25 | 12.8% | 11.5% | ||
| Q2 25 | 12.2% | 14.0% | ||
| Q1 25 | 7.9% | 7.4% | ||
| Q4 24 | 59.1% | -13.9% | ||
| Q3 24 | 12.6% | 7.6% | ||
| Q2 24 | 12.6% | 12.2% |
净利率ACADSAM
| Q1 26 | 1.4% | — | ||
| Q4 25 | 96.3% | -5.8% | ||
| Q3 25 | 25.8% | 8.6% | ||
| Q2 25 | 10.1% | 10.3% | ||
| Q1 25 | 7.8% | 5.4% | ||
| Q4 24 | 55.4% | -9.6% | ||
| Q3 24 | 13.1% | 5.5% | ||
| Q2 24 | 13.8% | 9.0% |
每股收益（稀释后）ACADSAM
| Q1 26 | $0.02 | $2.16 | ||
| Q4 25 | $1.61 | $-1.97 | ||
| Q3 25 | $0.42 | $4.25 | ||
| Q2 25 | $0.16 | $5.45 | ||
| Q1 25 | $0.11 | $2.16 | ||
| Q4 24 | $0.86 | $-3.23 | ||
| Q3 24 | $0.20 | $2.86 | ||
| Q2 24 | $0.20 | $4.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $164.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $682.6M |
| 总资产 | $1.6B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACADSAM
| Q1 26 | — | $164.1M | ||
| Q4 25 | $177.7M | $223.4M | ||
| Q3 25 | $258.0M | $250.5M | ||
| Q2 25 | $253.6M | $212.4M | ||
| Q1 25 | $217.7M | $152.5M | ||
| Q4 24 | $319.6M | $211.8M | ||
| Q3 24 | $155.1M | $255.6M | ||
| Q2 24 | $177.1M | $219.3M |
股东权益ACADSAM
| Q1 26 | — | $682.6M | ||
| Q4 25 | $1.2B | $846.3M | ||
| Q3 25 | $917.3M | $911.0M | ||
| Q2 25 | $822.4M | $912.3M | ||
| Q1 25 | $765.2M | $897.0M | ||
| Q4 24 | $732.8M | $916.2M | ||
| Q3 24 | $577.2M | $1.0B | ||
| Q2 24 | $516.7M | $1.0B |
总资产ACADSAM
| Q1 26 | $1.6B | $1.2B | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $976.9M | $1.4B | ||
| Q2 24 | $914.1M | $1.4B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
